Conversations in Healthcare
How Healx uses AI to transform rare disease drug discovery
Share this episode
In this episode of Conversations in Healthcare, Mike Ward speaks with Dr. Tim Guilliams, the co-founder and CEO of Healx. Healx is an artificial intelligence-powered technology company that’s dedicated to helping rare disease patients access life improving treatments. Mike and Tim discuss the company’s innovative approach to drug discovery, choosing which rare diseases to target and how patients are shaping their priorities. Learn more in the full episode, which was recorded in collaboration with One Nucleus’s ON Helix conference (June 2021).
Clarivate Conversations in Healthcare is a series of candid interviews with industry leaders and experts on the key trends and challenges that are shaping the future of the healthcare industry. Topics include from clinical innovation, deal-making, market access and regulatory dynamics, data and technology, new engagement models, patient centricity, diversity, COVID-19 and much more. Subscribe for episodes here.
